LONDON – Wellington Partners has reported the final close of its fifth fund at €210 million (US$234 million), well above the initial target range of €120 million to €150 million. Closing the Wellington Partners life sciences fund V (WPLS-V) at more than double the previous fund is a testament to investor appetite for Wellington's strategy, as well as to its experience and track record in life sciences, said Regina Hodits, managing partner.